SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Sullivan Eric

(Last) (First) (Middle)
C/O BLUEBIRD BIO, INC.
60 BINNEY STREET

(Street)
CAMBRIDGE MA 02142

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
bluebird bio, Inc. [ BLUE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Principal Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/06/2017
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/05/2017 M 250 A $20.7 6,657 D
Common Stock 07/05/2017 M 196 A $24.47 6,853 D
Common Stock 07/05/2017 M 201 A $50.51 7,054 D
Common Stock 07/05/2017 M 2,933 A $56.3 9,987 D
Common Stock 07/05/2017 S 3,580 D $107.2936(1) 6,407 D
Common Stock 07/05/2017 S 733(2) D $107.2242(3) 5,674 D
Common Stock 300 I By spouse(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to buy) $20.7 07/05/2017 M 250 (5) 12/02/2023 Common Stock 250 $0.00 1,000 D
Stock Option (right to buy) $24.47 07/05/2017 M 196 (6) 03/03/2024 Common Stock 196 $0.00 1,020 D
Stock Option (right to buy) $50.51 07/05/2017 M 201 (7) 03/01/2026 Common Stock 201 $0.00 6,069 D
Stock Option (right to buy $56.3 07/05/2017 M 2,933 (8) 08/01/2026 Common Stock 2,933 $0.00 8,802 D
Explanation of Responses:
1. The range in prices for the transaction reported on this line was $107.25 to $107.40. The average weighted price was $107.2936. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
2. Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
3. The range in prices for the transaction reported on this line was $107.15 to $107.30. The average weighted price was $107.2242. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
4. Equity grants held by the reporting person's spouse, who is employed by the issuer
5. This option vests over a four-year period, at a rate of twenty-five percent (25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
6. This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
7. This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2017, and in 36 equal monthly installments.
8. This option vests over a four-year period, at a rate of twenty-five percent (25%) on July 4, 2017 and in 36 equal monthly installments thereafter.
Remarks:
/s/ Jason F. Cole, Attorney-in-Fact 07/07/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.